KENILWORTH, N.J., Feb. 8 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) today announced leadership and organizational changes at Schering-Plough Research Institute (SPRI), the research and development arm of Schering-Plough.
Jacqueline Elbonne, Ph.D., has been named vice president, Global Research Quality, SPRI, effective immediately. In this position, Elbonne will build and lead a worldwide research quality team overseeing all SPRI activities governed by current Good Manufacturing Practices, Good Laboratory Practices, Good Clinical Practices and Good Pharmacovigilance Practices. In addition, she will direct and govern the design, implementation and performance management of global research Quality Management Systems to meet regulatory requirements and expectations worldwide. Elbonne will report directly to Thomas P. Koestler, Ph.D., executive vice president and president of SPRI, with shared accountability for SPRI quality systems to Richard S. Bowles III, senior vice president, Global Quality Operations.
Elbonne joined Schering-Plough in 2000 and has since held various positions of increasing responsibility in SPRI, Analytical Development and Global Quality. She recently served as vice president, Pharmaceutical Sciences Quality, providing quality leadership overseeing global clinical manufacturing operations, which included meeting all commitments under the U.S. consent decree. She earned a Ph.D. in organic chemistry and a Bachelor of Science degree in chemistry and pharmacology from the University of Liverpool, England.
The following new positions were created in response to the company's
expanded product portfolio following the acquisition of Organon
BioSciences. Effective immediately, Martin H.
|SOURCE Schering-Plough Corporation|
Copyright©2008 PR Newswire.
All rights reserved